Abbvie’s RINVOQ® (upadacitinib) Approved by U.S. FDA as an Oral Treatment for Adults with Active Ankylosing Spondylitis
May 4, 2022 | BioForward Member News
Events
July 2022
Jul 21 2022
Women in Biohealth Networking Event
East Side Business Club
August 2022
Aug 15 - 19 2022
The Forward Festival
Aug 17 2022
BioForward & Fisher Scientific Customer Appreciation Luncheon
BioForward's New Office at URP
Aug 25 2022
LEAD THE MOVEMENT – Business Conference
Fiserv Forum
September 2022
Sep 14 2022
FOUNDER/FEST V – Milwaukee Founders Community 1st Birthday Party
Water Street Garage
October 2022
Oct 12 2022
BioForward Wisconsin Biohealth Summit
Overture Center for the Arts,
Oct 24 - 26 2022
The 2022 MedTech Conference
Boston, Massachusetts
December 2022
Dec 08 2022
BioForward End-of-Year Celebration
No event found!